[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Locht et al., 1993 - Google Patents

Severe skin necrosis following warfarin therapy in a patient with protein C deficiency

Locht et al., 1993

Document ID
12840001622152461618
Author
Locht H
Lindström F
Publication year
Publication venue
Journal of internal medicine

External Links

Snippet

A female patient with a history of both arterial and venous thrombosis developed extensive skin necrosis following warfarin treatment. When protein C deficiency was diagnosed, successful anticoagulation with warfarin was achieved by prolonging the course of …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

Similar Documents

Publication Publication Date Title
Wada et al. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation
WHITE et al. Thrombotic complications of heparin therapy including six cases of heparin-induced skin necrosis
Marciniak et al. Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood
Marder et al. Clinical aspects of congenital factor VII deficiency
Buller et al. Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate
Essex et al. Late‐onset warfarin‐induced skin necrosis: case report and review of the literature
Berrettini et al. Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency
Pitney et al. Blood fibrinolytic activity during Arvin therapy
McKenna Abnormal coagulation in the postoperative period contributing to excessive bleeding
Soff et al. Familial multiple coagulation factor deficiencies
Gitel et al. The antithrombotic effects of warfarin and heparin following infusions of tissue thromboplastin in rabbits: clinical implications
Sussman et al. Clinical application of simplified serum prothrombin consumption test
Pescatore et al. Problems of oral anticoagulation in an adult with homozygous protein C deficiency and late onset of thrombosis
Locht et al. Severe skin necrosis following warfarin therapy in a patient with protein C deficiency
Eisenmenger et al. Hypercoagulability of the blood of patients with hepatic cirrhosis following administration of ACTH
Horowitz et al. Acquired hemophilia due to a circulating anticoagulant: Report of two cases, with review of the literature
Cacciola et al. Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta thalassemia: a pilot study
Pedersen et al. Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease
AU674864B2 (en) Pharmaceutical composition containing IL-6, their uses for the treatment of consumptive thrombo-hemorrhagic disorder
Schalekamp Renin-angiotensin system components and endothelial proteins as markers of diabetic microvascular disease
Crisnic et al. Disseminated intravascular coagulation and acute renal failure
Chu et al. Abnormal fibrinolytic activity in systemic lupus erythematosus and possible mechanisms
Girolami et al. Homozygous patients with APC resistance may remain paucisymptomatic or asymptomatic during oral contraception
Eber et al. Favorable response of pediatric stem cell recipients to human protein C concentrate substitution for veno‐occlusive disease
Niklasson et al. Thrombocytopenia and bleeding complications in severe cases of meningococcal infection treated with heparin, dextran 70 and chlorpromazine